Healthcare provider profile · identity verified

Edward A Dickes, M.D.

Internal Medicine · WATERTOWN, SD · NPI 1932411733

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	133
Levothyroxine Sodium	Levothyroxine Sodium	398	78
Amlodipine Besylate	Amlodipine Besylate	307	78
Lisinopril	Lisinopril	302	82
Pantoprazole Sodium	Pantoprazole Sodium	282	73
Gabapentin	Gabapentin	260	65
Furosemide	Furosemide	245	60
Omeprazole	Omeprazole	231	64
Potassium Chloride	Potassium Chloride	223	51
Losartan Potassium	Losartan Potassium	214	54
Tamsulosin Hcl	Tamsulosin Hcl	208	51
Rosuvastatin Calcium	Rosuvastatin Calcium	178	55
Metoprolol Succinate	Metoprolol Succinate	166	46
Metformin Hcl	Metformin Hcl	161	40
Simvastatin	Simvastatin	160	43
Carvedilol	Carvedilol	124	30
Warfarin Sodium	Warfarin Sodium	123	21
Citalopram Hbr	Citalopram Hydrobromide	122	36
Eliquis	Apixaban	119	24
Metoprolol Tartrate	Metoprolol Tartrate	119	31
Topiramate	Topiramate	119	16
Glipizide Er	Glipizide	115	30
Prednisone	Prednisone	109	43
Hydrochlorothiazide	Hydrochlorothiazide	108	30
Mirtazapine	Mirtazapine	108	22
Metformin Hcl Er	Metformin Hcl	101	30
Donepezil Hcl	Donepezil Hcl	97	22
Jardiance	Empagliflozin	92	22
Clopidogrel	Clopidogrel Bisulfate	84	19
Allopurinol	Allopurinol	83	22
Ozempic	Semaglutide	80	16
Trazodone Hcl	Trazodone Hcl	74	17
Quetiapine Fumarate	Quetiapine Fumarate	73	11
Tramadol Hcl	Tramadol Hcl	69	17
Duloxetine Hcl	Duloxetine Hcl	65	19
Ezetimibe	Ezetimibe	65	16
Sertraline Hcl	Sertraline Hcl	65	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	14
Montelukast Sodium	Montelukast Sodium	56	15
Oxybutynin Chloride	Oxybutynin Chloride	56	suppressed
Spironolactone	Spironolactone	55	15
Famotidine	Famotidine	51	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	11
Albuterol Sulfate Hfa	Albuterol Sulfate	50	25
Atenolol	Atenolol	50	11
Mounjaro	Tirzepatide	50	suppressed
Sucralfate	Sucralfate	49	16
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Fluticasone Propionate	Fluticasone Propionate	46	15
Olmesartan Medoxomil	Olmesartan Medoxomil	46	13
Pioglitazone Hcl	Pioglitazone Hcl	46	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	11
Finasteride	Finasteride	42	suppressed
Meloxicam	Meloxicam	42	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Lorazepam	Lorazepam	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Alendronate Sodium	Alendronate Sodium	37	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	26
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	15
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Cephalexin	Cephalexin	32	24
Januvia	Sitagliptin Phosphate	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	11
Doxycycline Hyclate	Doxycycline Hyclate	29	13
Farxiga	Dapagliflozin Propanediol	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	11
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	15
Baclofen	Baclofen	24	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Dutasteride	Dutasteride	24	suppressed
Torsemide	Torsemide	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	22
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Naproxen	Naproxen	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	18	suppressed
Trimethoprim	Trimethoprim	18	suppressed
Ursodiol	Ursodiol	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Nitroglycerin	Nitroglycerin	15	13
Trulicity	Dulaglutide	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nyamyc	Nystatin	14	suppressed
Nystatin	Nystatin	14	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	14	suppressed
Risperidone	Risperidone	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Glipizide	Glipizide	13	suppressed
Primidone	Primidone	13	suppressed
Rytary	Carbidopa/Levodopa	13	suppressed
Temazepam	Temazepam	13	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Glimepiride	Glimepiride	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error